Cigna Group $CI Shares Purchased by Robeco Institutional Asset Management B.V.

Key Points

• Robeco Institutional Asset Management B.V. increased its stake in Cigna Group by 16.6% in the second quarter, acquiring an additional 7,517 shares, bringing its total holdings to 52,688 shares valued at approximately $17.4 million.
• Analysts have varied opinions on Cigna Group, with two analysts rating it as a "Strong Buy", while 14 have given it a "Buy" rating and three a "Hold" rating, reflecting a consensus average rating of "Moderate Buy."
• Cigna Group reported $67.13 billion in revenue for the last quarter, significantly exceeding analyst expectations, and achieved $7.20 earnings per share, surpassing estimates by $0.05.

Robeco Institutional Asset Management B.V. raised its stake in Cigna Group (NYSE:CI - Free Report) by 16.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 52,688 shares of the health services provider's stock after purchasing an additional 7,517 shares during the period. Robeco Institutional Asset Management B.V.'s holdings in Cigna Group were worth $17,418,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of CI. Brighton Jones LLC grew its holdings in shares of Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock worth $1,032,000 after purchasing an additional 318 shares during the last quarter. NBC Securities Inc. purchased a new position in Cigna Group during the 1st quarter worth approximately $123,000. RFG Advisory LLC acquired a new position in Cigna Group during the first quarter worth approximately $233,000. Hennion & Walsh Asset Management Inc. lifted its stake in Cigna Group by 13.5% in the first quarter. Hennion & Walsh Asset Management Inc. now owns 1,212 shares of the health services provider's stock valued at $399,000 after buying an additional 144 shares during the last quarter. Finally, Signal Advisors Wealth LLC boosted its holdings in shares of Cigna Group by 106.2% in the first quarter. Signal Advisors Wealth LLC now owns 1,827 shares of the health services provider's stock valued at $601,000 after acquiring an additional 941 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have recently commented on CI. Deutsche Bank Aktiengesellschaft set a $415.00 target price on shares of Cigna Group and gave the company a "buy" rating in a report on Tuesday, August 5th. Weiss Ratings restated a "hold (c+)" rating on shares of Cigna Group in a research note on Saturday, September 27th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $365.00 target price on shares of Cigna Group in a report on Tuesday, August 26th. TD Cowen raised Cigna Group to a "strong-buy" rating in a report on Monday, June 23rd. Finally, Wall Street Zen downgraded Cigna Group from a "buy" rating to a "hold" rating in a research note on Friday. Two analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Cigna Group has an average rating of "Moderate Buy" and an average target price of $371.81.

Cigna Group Stock Performance

NYSE CI opened at $311.24 on Friday. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The business's 50 day moving average is $292.41 and its two-hundred day moving average is $309.73. The stock has a market capitalization of $83.08 billion, a price-to-earnings ratio of 16.99, a PEG ratio of 0.91 and a beta of 0.45. Cigna Group has a 12-month low of $256.89 and a 12-month high of $358.88.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping analysts' consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. During the same quarter in the prior year, the company posted $6.72 earnings per share. Cigna Group's quarterly revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were paid a $1.51 dividend. The ex-dividend date was Thursday, September 4th. This represents a $6.04 annualized dividend and a dividend yield of 1.9%. Cigna Group's dividend payout ratio (DPR) is 32.97%.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the company's stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.70% of the company's stock.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.